Search Results
… mutations in the ATP7A gene that regulates the metabolism of copper in the body. The disease primarily affects male … the disease is rarely treated early enough to make a significant difference. The prognosis for babies with … clinical research visit NIH Clinical Research Trials and You . Learn about clinical trials currently looking for …
… cerebri? Pseudotumor cerebri literally means "false brain tumor." It is likely due to high pressure within the skull caused by the buildup or poor absorption of cerebrospinal fluid (CSF). The disorder is most common in …
… of prioritizations are used. The first critical factor is the reviewer ratings. The highest ratings go to applicants … in the LRP program and policy guidance, this information is not reviewed as a research or training grant would be – the research itself is not being critiqued. What is critical is the thoughtfulness of the planning, in …
… with an emphasis on toxicant induced Parkinson-like symptoms in Drosophila. … …
… Program Specialist Image Division of Neuroscience Movement Disorders and Neurodegeneration Contact … is a Health Program Specialist in the Movement Disorders and Neurodegeneration (MDN) cluster of the Division …
General Notes
- FY 2023 Enacted levels cited in this document include the effects of the FY 2023 HIV/AIDS transfer, as shown in the Amounts Available for Obligation table.
- Detail in this document may not sum to the subtotals and totals due to rounding.
Monday, November 6, 2023
As the leaves change colors this fall and 2023 rapidly comes to an end, Washington, D.C. will once again host the world's largest convening of neuroscientists at the annual meeting of the Society for Neuroscience, taking place from November 11-15. Simply put, it is one of my favorite times of the year as we benefit from front row seats to the latest cutting-edge scientific advances, take time to catch up with old friends, and connect…
… pain. To that end, HEAL embarked on development of a new strategic plan in 2024. As part of that effort, an … to opioids. Identifying and rigorously validating new targets for pain treatments will lower the risk of adopting the target in translational projects to …
… knowledge to reduce the burden of neurological disease for all people. 2025 will mark our 75th anniversary as a leader in … brain and spinal cord stimulation therapies for chronic pain, Parkinson’s disease, depression, and obsessive …